Samrudh Pharmacare Profile
Key Indicators
- Authorised Capital ₹ 5.00 Cr
as on 17-12-2024
- Paid Up Capital ₹ 3.44 Cr
as on 17-12-2024
- Company Age 29 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.65 Cr
as on 17-12-2024
- Satisfied Charges ₹ 13.61 Cr
as on 17-12-2024
- Revenue 6.26%
(FY 2022)
- Profit -35.58%
(FY 2022)
- Ebitda -6.53%
(FY 2022)
- Net Worth 45.12%
(FY 2022)
- Total Assets -0.50%
(FY 2022)
About Samrudh Pharmacare
The Corporate was formerly known as Samrudh Packaging Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 3.44 Cr.
The company currently has active open charges totaling ₹7.65 Cr. The company has closed loans amounting to ₹13.61 Cr, as per Ministry of Corporate Affairs (MCA) records.
Alok Sheth, Sharad Sheth, Piyush Shah, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999MH1995PTC088618
- Company No.
088618
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 May 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Samrudh Pharmacare?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alok Sheth  | Whole-Time Director | 01-Apr-2002 | Current |
| Sharad Sheth | Whole-Time Director | 22-May-1995 | Current |
| Piyush Shah | Whole-Time Director | 22-May-1995 | Current |
| Darshit Shah | Director | 10-Dec-2013 | Current |
Financial Performance and Corporate Structure Insights of Samrudh Pharmacare.
Samrudh Pharmacare Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 6.26% increase. The company also saw a substantial fall in profitability, with a 35.58% decrease in profit. The company's net worth Soared by an impressive increase of 45.12%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Samrudh Pharmacare?
In 2021, Samrudh Pharmacare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Samrudh Healthcare Private LimitedActive 27 years 1 monthAlok Sheth and Sharad Sheth are mutual person
- Samrudh Pharmaceuticals Private LimitedActive 33 years 7 months
Alok Sheth and Sharad Sheth are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of India Creation Date: 24 Feb 2021 | ₹7.65 Cr | Open |
Bank Of India Creation Date: 10 Oct 2019 | ₹1.30 M | Satisfied |
Bank Of India Creation Date: 30 Jul 2012 | ₹13.48 Cr | Satisfied |
How Many Employees Work at Samrudh Pharmacare?
Unlock and access historical data on people associated with Samrudh Pharmacare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Samrudh Pharmacare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samrudh Pharmacare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
